Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer
- 24 April 2020
- Vol. 126 (13), 2991-3001
- https://doi.org/10.1002/cncr.32912
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30CA072720)
This publication has 22 references indexed in Scilit:
- Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant TrialJournal of Urology, 2018
- Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseasesUrologic Oncology: Seminars and Original Investigations, 2017
- Epidemiology of Renal Cell CarcinomaPublished by Springer Science and Business Media LLC ,2017
- Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical ResectionEuropean Urology, 2017
- Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 ExperienceJournal of Urology, 2015
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Lymphadenectomy Improves Survival of Patients With Renal Cell Carcinoma and Nodal MetastasesJournal of Urology, 2011
- Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881European Urology, 2008
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific SurvivalEuropean Urology, 2007